Special Purpose Technology Platforms
As the need arises for specialty molecules to treat chronic diseases, and as new technologies become available to produce natural, synthetic and bio-synthetic APIs with better results, Noramco will adopt special purpose technology platforms.
These include, but are not limited to platforms pertaining to:
– Production of cannabinoid-based APIs
– Custom synthesis products
– APIs produced by bio-catalysis
– Controlled substance building blocks and intermediates